CoChat

Antiangiogenic Actions of Vascular Endothelial Growth Factor-A 165 b, an Inhibitory Isoform of Vascular Endothelial Growth Factor-A, in Human Obesity

Open access
Ngo, Doan T.M., Farb, Melissa G., Kikuchi, Ryosuke, Karki, Shakun, Tiwari, Stephanie, Bigornia, Sherman J., Bates, David O., LaValley, Michael P., Hamburg, Naomi M., Vita, Joseph A., Hess, Donald T., Walsh, Kenneth, Gokce, Noyan · 2014 · Circulation
Cited by 81

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

Background—: Experimental studies suggest that visceral adiposity and adipose tissue dysfunction play a central role in obesity-related cardiometabolic complications. Impaired angiogenesis in fat has been implicated in the development of adipose tissue hypoxia, capillary rarefaction, inflammation, and metabolic dysregulation, but pathophysiological mechanisms remain unknown. In this study, we examined the role of a novel antiangiogenic isoform of vascular endothelial growth factor-A (VEGF-A), VEGF-A 165 b, in human obesity. Methods and Results—: We biopsied paired subcutaneous and visceral adipose tissue in 40 obese subjects (body mass index, 45±8 kg/m 2 ; age, 45±11 years) during bariatric surgery and characterized depot-specific adipose tissue angiogenic capacity using an established ex vivo assay. Visceral adipose tissue exhibited significantly blunted angiogenic growth compared with subcutaneous fat ( P <0.001) that was associated with marked tissue upregulation of VEGF-A 165 b ( P =0.004). The extent of VEGF-A 165 b expression correlated negatively with angiogenic growth ( r =−0.6, P =0.006). Although recombinant VEGF-A 165 b significantly impaired angiogenesis, targeted inhibition of VEGF-A 165 b with neutralizing antibody stimulated fat pad neovascularization and restored VEGF receptor activation. Blood levels of VEGF-A 165 b were significantly higher in obese subjects compared with lean control subjects ( P =0.02), and surgical weight loss induced a marked decline in serumVEGF-A 165 b ( P =0.003). Conclusions—: We demonstrate that impaired adipose tissue angiogenesis is associated with overexpression of a novel antiangiogenic factor, VEGF-A 165 b, that may play a pathogenic role in human adiposopathy. Moreover, systemic upregulation of VEGF-A 165 b in circulating blood may have wider-ranging implications beyond the adipose milieu. VEGF-A 165 b may represent a novel area of investigation to gain further understanding of mechanisms that modulate the cardiometabolic consequences of obesity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/circulationaha.113.008171

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 81

Metadata

Authors
Ngo, D. T. M., Farb, M. G., Kikuchi, R., Karki, S., Tiwari, S., Bigornia, S. J., Bates, D. O., LaValley, M. P., Hamburg, N. M., Vita, J. A., Hess, D. T., Walsh, K., & Gokce, N.
Venue
Circulation
Published
2014-09-23
Volume
130
Issue
13
Pages
1072-1080
ISSN
  • 0009-7322 (ISSN-L)
  • 1524-4539
OpenAlex
W2143726472
Cited by
81
References
5
FWCI
4.02
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antiangiogenic Actions of Vascular Endothelial Growth Factor-A 165 b, an Inhibitory Isoform of Vascular Endothelial Growth Factor-A, in Human Obesity. https://app.cochat.ai/papers/10.1161/circulationaha.113.008171
The paper
Ngo, D. T. M., Farb, M. G., Kikuchi, R., Karki, S., Tiwari, S., Bigornia, S. J., Bates, D. O., LaValley, M. P., Hamburg, N. M., Vita, J. A., Hess, D. T., Walsh, K., & Gokce, N. (2014). Antiangiogenic Actions of Vascular Endothelial Growth Factor-A 165 b, an Inhibitory Isoform of Vascular Endothelial Growth Factor-A, in Human Obesity. Circulation. https://doi.org/10.1161/circulationaha.113.008171

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.